Cutler Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,000
| Closed | -$3K | – | 4239 |
|
|
2023
Q3 | $3K | Buy |
3,000
+2,600
| +650% | +$75.1K | ﹤0.01% | 3148 |
|
|
2023
Q2 | $2K | Buy |
400
+200
| +100% | +$9.95K | ﹤0.01% | 3100 |
|
|
2023
Q1 | $1K | Buy |
200
+100
| +100% | +$4.3K | ﹤0.01% | 3543 |
|
|
2022
Q4 | $1K | Sell |
100
-200
| -67% | -$7.64K | ﹤0.01% | 4141 |
|
|
2022
Q3 | $1K | Sell |
300
-400
| -57% | -$15.5K | ﹤0.01% | 4663 |
|
|
2022
Q2 | $8K | Sell |
700
-100
| -13% | -$3.35K | ﹤0.01% | 3392 |
|
|
2022
Q1 | $8K | Sell |
800
-300
| -27% | -$11.3K | ﹤0.01% | 3803 |
|
|
2021
Q4 | $21K | Sell |
1,100
-200
| -15% | -$8.37K | ﹤0.01% | 3092 |
|
|
2021
Q3 | $22K | Sell |
1,300
-15,100
| -92% | -$692K | ﹤0.01% | 3278 |
|
|
2021
Q2 | $52K | Buy |
16,400
+11,600
| +242% | +$820K | ﹤0.01% | 2448 |
|
|
2021
Q1 | $41K | Sell |
4,800
-7,300
| -60% | -$599K | ﹤0.01% | 2563 |
|
|
2020
Q4 | $26K | Buy |
+12,100
| New | +$892K | ﹤0.01% | 2487 |
|
|
2020
Q3 | – | Sell |
-4,000
| Closed | -$7K | – | 5184 |
|
|
2020
Q2 | $7K | Buy |
4,000
+1,800
| +82% | +$65.3K | ﹤0.01% | 3116 |
|
|
2020
Q1 | $58K | Sell |
2,200
-21,700
| -91% | -$1.26M | ﹤0.01% | 1640 |
|
|
2019
Q4 | $392K | Buy |
23,900
+16,100
| +206% | +$1.98M | 0.02% | 534 |
|
|
2019
Q3 | $151K | Buy |
7,800
+7,500
| +2,500% | +$1.25M | 0.01% | 842 |
|
|
2019
Q2 | $4K | Sell |
300
-6,000
| -95% | -$1.02M | ﹤0.01% | 3254 |
|
|
2019
Q1 | $12K | Buy |
6,300
+500
| +9% | +$72.4K | ﹤0.01% | 2398 |
|
|
2018
Q4 | $114K | Buy |
5,800
+3,500
| +152% | +$401K | 0.01% | 952 |
|
|
2018
Q3 | $1K | Hold |
2,300
| – | – | ﹤0.01% | 3854 |
|
|
2018
Q2 | $2K | Sell |
2,300
-15,800
| -87% | -$2.48M | ﹤0.01% | 3618 |
|
|
2018
Q1 | $62K | Sell |
18,100
-32,800
| -64% | -$5.57M | 0.01% | 1513 |
|
|
2017
Q4 | $42K | Buy |
50,900
+10,700
| +27% | +$1.04M | ﹤0.01% | 2007 |
|
|
2017
Q3 | $249K | Sell |
40,200
-28,800
| -42% | -$2.26M | 0.01% | 1036 |
|
|
2017
Q2 | $249K | Buy |
69,000
+34,900
| +102% | +$2.52M | 0.01% | 1118 |
|
|
2017
Q1 | $133K | Buy |
34,100
+20,400
| +149% | +$1.19M | 0.01% | 1492 |
|
|
2016
Q4 | $33K | Sell |
13,700
-89,500
| -87% | -$4.22M | ﹤0.01% | 2959 |
|
|
2016
Q3 | $148K | Buy |
103,200
+62,700
| +155% | +$2.55M | 0.01% | 1477 |
|
|
2016
Q2 | $147K | Buy |
40,500
+39,900
| +6,650% | +$1.33M | 0.01% | 1363 |
|
|
2016
Q1 | $3K | Buy |
+600
| New | +$21.1K | ﹤0.01% | 5322 |
|
Other funds holding SAGE
RI
BG
